Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale

Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale

Abstract Background Epidermolysis bullosa (EB) is a group of rare, genetic diseases that affect the integrity of epithelial tissues, most notably the skin. Patients experience recurrent skin wounding, with severity depending on type, sub-type, and mutation. Oleogel-S10, a formulation of birch bark e...

Full description

Bibliographic Details
Main Authors: Johannes S. Kern, Agnes Schwieger-Briel, Sandra Löwe, Mark Sumeray, Charles Davis, Anna E. Martinez
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Trials
Subjects:
Epidermolysis bullosa
Kindler syndrome
Oleogel
Birch bark
Betulin
Trial design
Online Access:http://link.springer.com/article/10.1186/s13063-019-3362-z

Internet

http://link.springer.com/article/10.1186/s13063-019-3362-z

Similar Items